Grantee | Grant description | Grant year | Amount |
---|---|---|---|
The Translational Genomics Research Institute | Fundraising for Tgen | 2023-09 | $14,873,631 |
Grantmaker | Grantmaker tax period | Description | Amount |
---|---|---|---|
The Robert and Lynda Altman Family Foundation | 2022-12 | General Purpose | $4,325,684 |
The Robert and Lynda Altman Family Foundation | 2022-12 | Establishment of the Robert & Lynda Carter Altman Family Research Fund With Tgen and Its Affiliate, City of Hope, To Facilitate Research Efforts in Two Complementary Areas Specifically Designed for Rapid Improvement of Patient Outcomes Who Suffer From Mpn/saml. One Research Project, the Diagnostic Research Project, Is To Be Conducted By Tgen To Develop Two Diagnostic Tests. the First Diagnostic Research Project Is To Identify the Most Sensitive Test for the Transition From MPN To Saml. the Second Diagnostic Research Project Is To Develop and Deploy An Ultra-Rapid Whole Genomic Sequencing Test To Identify Drug Treatment Options for Patients Who Have Transitioned From MPN To Saml. | $3,070,884 |
The Robert and Lynda Altman Family Foundation | 2022-12 | Establishment of the Robert & Lynda Carter Altman Family Research Fund With Tgen and Its Affiliate, City of Hope, To Facilitate Research Efforts in Two Complementary Areas Specifically Designed for Rapid Improvement of Patient Outcomes Who Suffer From Mpn/saml. One Research Project, the Therapeutic Research Project, To Be Conducted By the City of Hope Will Comprehensively Test and Scale Up the Manufacture of the Drug Denominated As Mir-142. This "mimetic" Drug Simulates (Replaces) the Action of A Normal Signal That Is Missing in Mpn/saml Patients. | $1,254,800 |
...and 36 more grants received totalling $12,665,704 |
Name | Title | Compensation | Date of data |
---|---|---|---|
Manuel Estrada | Chief Financial Officer , Tgen | $0 | 2023-09-30 |
Erin Massey | Chief Development Officer | $0 | 2024-08-13 |
Stephanie Grinage | Vice President, Individual Giving | 2023-01-23 | |
Dean Ballard | Director of Development | 2024-04-25 | |
Janita Gordon | Senior Director, Individual Giving Tgen Foundation | 2024-04-25 | |
...and 9 more key personnel |
Revenues | FYE 09/2023 |
---|---|
Total grants, contributions, etc. | $14,552,517 |
Program services | $0 |
Investment income and dividends | $848,247 |
Tax-exempt bond proceeds | $0 |
Royalty revenue | $0 |
Net rental income | $0 |
Net gain from sale of non-inventory assets | $0 |
Net income from fundraising events | $0 |
Net income from gaming activities | $0 |
Net income from sales of inventory | $0 |
Miscellaneous revenues | $0 |
Total revenues | $15,400,764 |
Fiscal year ending | Date received by IRS | Form | PDF link |
---|---|---|---|
2023-09 | 2024-08-13 | 990 | View PDF |
2022-09 | 2023-08-14 | 990 | View PDF |
2021-09 | 2022-08-08 | 990 | View PDF |
2020-09 | 2021-08-12 | 990 | View PDF |
2019-09 | 2020-10-13 | 990 | View PDF |
...and 11 more Form 990s |
Organization | Type | Location | Revenue |
---|---|---|---|
American Association for Cancer Research Foundation | 501(c)(3) | Philadelphia, PA | $19,004,303 |
Pap Corps Champions for Cancer Research | 501(c)(3) | Deerfield Beach, FL | $9,983,831 |
Cancer Research Institute (CRI) | 501(c)(3) | New York, NY | $32,295,259 |
Metavivor Research and Support | 501(c)(3) | Annapolis, MD | $5,273,267 |
H Lee Moffitt Cancer Center and Research Institute Foundation | 501(c)(3) | Tampa, FL | $34,168,930 |
Damon Runyon Cancer Research Foundation | 501(c)(3) | New York, NY | $15,715,675 |
Stanley Medical Research Institute (SMRI) | 501(c)(3) | Rockville, MD | $4,628,611 |
Pedal the Cause - San Diego | 501(c)(3) | San Diego, CA | $10,395,528 |
Melanoma Research Alliance (MRA) | 501(c)(3) | Washington, DC | $11,614,639 |
Advanced Medical Research Foundation Incd / B / A Nile Albright Research Foundation (AMRF) | 501(c)(3) | Brookline, MA | $3,999,706 |
Want updates when TGen Foundation has new information, or want to find more organizations like TGen Foundation?
Create free Cause IQ account